Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K H Orchard
Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Impact of Pretransplant Comorbidities on Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Hematopoietic SCT for Patients With High-Risk Myelodysplastic Syndrome and AML
Bone Marrow Transplantation
Transplantation
Hematology
Reduced Toxicity, Myeloablative Conditioning With BU, Fludarabine, Alemtuzumab and SCT From Sibling Donors in Children With Sickle Cell Disease
Bone Marrow Transplantation
Transplantation
Hematology
Plasma Levels of IL-7 and IL-15 After Reduced Intensity Conditioned Allo-SCT and Relationship to Acute GVHD
Bone Marrow Transplantation
Transplantation
Hematology
Chronic GVHD Induced GVL Effect After Unmanipulated Haploidentical Hematopoietic SCT for AML and Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Disease Status Is a More Reliable Predictive Factor Than Histology in Lymphoma Patients After Reduced-Intensity Conditioning Regimen and Allo-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Oral Cryotherapy Can Significantly Reduce Oral Mucositis but Not Acute GVHD Incidence in Flu/Mel Conditioning Allo-SCT
Bone Marrow Transplantation
Transplantation
Hematology
Leukemia Burden Delays Lymphocyte and Platelet Recovery After Allo-SCT for AML
Bone Marrow Transplantation
Transplantation
Hematology
Mucous Membrane Pemphigoid Following Reduced Intensity Conditioning Allogeneic Haematopoietic SCT for Biphenotypic Leukaemia
Bone Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Conditioning Using Fludarabine, Melphalan and Thiotepa for Adult Patients Undergoing Haploidentical SCT
Bone Marrow Transplantation
Transplantation
Hematology
